Neuroprotective effects of the survival promoting peptide Y-P30

European Journal of Pharmacology

Volumn 616, Issue 1-3, 2009, Pages 81-85

  Schneeberg, Jenny ^a   Riek Burchardt, Monika ^a   Braun, Holger ^a   Landgraf, Peter ^a   Kreutz, Michael R ^a   Reymann, Klaus G ^a,b  

^a LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^b Research Institute for Applied Neuroscience (FAN gGmbH)   (Germany)

Author keywords

Neuroprotection; Organotypic hippocampal slice; Oxygen glucose deprivation; Survival promoting factor; Y P30

Indexed keywords

GLUCOSE; NEUROPROTECTIVE AGENT; OXYGEN; POLYPEPTIDE; PROTEIN Y P30; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HIPPOCAMPUS; ISCHEMIA; NERVE CELL; NERVE CELL MEMBRANE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; GLUCOSE; HIPPOCAMPUS; NEURONS; NEUROPROTECTIVE AGENTS; OXYGEN; PEPTIDES; RATS; RATS, WISTAR; STROKE;

EID: 67651119867     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.05.029     Document Type: Article

References (18)

1. Cavaliere F., Amadio S., Dinkel K., Reymann K.G., and Volonte C. P2 receptor antagonist trinitrophenyl-adenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death. J. Pharmacol. Exp. Ther. 323 (2007) 70-77
2. Chechneva O., Dinkel K., Schrader D., and Reymann K.G. Identification and characterization of two neurogenic zones in interface organotypic hippocampal slice cultures. Neuroscience 136 (2005) 343-355
3. Cunningham T.J., Hodge L., Speicher D., Reim D., Tyler-Polsz C., Levitt P., Eagleson K., Kennedy S., and Wang Y. Identification of a survival-promoting peptide in medium conditioned by oxidatively stressed cell lines of nervous system origin. J. Neurosci. 18 (1998) 7047-7060
4. Cunningham T.J., Jing H., Wang Y., and Hodge L. Calreticulin binding and other biological activities of survival peptide Y-P30 including effects of systemic treatment of rats. Exp. Neurol. 163 (2000) 457-468
5. Gramage E., Alguacil L.F., and Herradon G. Pleiotrophin prevents cocaine-induced toxicity in vitro. Eur. J. Pharmacol. 595 (2008) 35-38
6. Hida H., Jung C.G., Wu C.Z., Kim H.J., Kodama Y., Masuda T., and Nishino H. Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur. J. Neurosci. 17 (2003) 2127-2134
7. Hida H., Masuda T., Sato T., Kim T.S., Misumi S., and Nishino H. Pleiotrophin promotes functional recovery after neural transplantation in rats. NeuroReport 18 (2007) 179-183
8. Landgraf P., Sieg F., Wahle P., Meyer G., Kreutz M.R., and Pape H.C. A maternal blood-borne factor promotes survival of the developing thalamus. FASEB J. 19 (2005) 225-227
9. Landgraf P., Wahle P., Pape H.C., Gundelfinger E.D., and Kreutz M.R. The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity. J. Biol. Chem. 283 (2008) 25036-25045
10. Maeda N., Nishiwaki T., Shintani T., Hamanaka H., and Noda M. 6B4 proteoglycan/phosphacan, an extracellular variant of receptor-like protein-tyrosine phosphatase zeta/RPTPbeta, binds pleiotrophin/heparin-binding growth-associated molecule (HB-GAM). J. Biol. Chem. 271 (1996) 21446-21452
11. Martinez-Sanchez M., Striggow F., Schröder U.H., Kahlert S., Reymann K.G., and Reiser G. Na(+) and Ca(2+) homeostasis pathways, cell death and protection after oxygen-glucose-deprivation in organotypic hippocampal slice cultures. Neuroscience 128 (2004) 729-740
12. Mi R., Chen W., and Hoke A. Pleiotrophin is a neurotrophic factor for spinal motor neurons. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 4664-4669
13. Mourlevat S., Debeir T., Ferrario J.E., Delbe J., Caruelle D., Lejeune O., Depienne C., Courty J., Raisman-Vozari R., and Ruberg M. Pleiotrophin mediates the neurotrophic effect of cyclic AMP on dopaminergic neurons: analysis of suppression-subtracted cDNA libraries and confirmation in vitro. Exp. Neurol. 194 (2005) 243-254
14. Neumann J., Gunzer M., Gutzeit H.O., Ullrich O., Reymann K.G., and Dinkel K. Microglia provide neuroprotection after ischemia. FASEB J. 20 (2006) 714-716
15. Schittek B., Hipfel R., Sauer B., Bauer J., Kalbacher H., Stevanovic S., Schirle M., Schroeder K., Blin N., Meier F., Rassner G., and Garbe C. Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat. Immunol. 2 (2001) 1133-1137
16. Stoica G.E., Kuo A., Aigner A., Sunitha I., Souttou B., Malerczyk C., Caughey D.J., Wen D., Karavanov A., Riegel A.T., and Wellstein A. Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin. J. Biol. Chem. 276 (2001) 16772-16779
17. Stoppini L., Buchs P.A., and Muller D. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37 (1991) 173-182
18. Todorov P., Cariuk P., McDevitt T., Coles B., Fearon K., and Tisdale M. Characterization of a cancer cachectic factor. Nature 379 (1996) 739-742